Page 2 - Lifesci Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications

Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France generalNew yorkUnited statesNorth carolinaPascalyne wilsonCellecti pulseagileJulien valtonPatricia sosa navarroArthur strilAshleyr robinsonSecurities exchange commissionNature communicationsCellectis the company euronext growthNon viral gene therapy approachSickle cell diseaseEuronext growth

Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications

NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell

France generalNew yorkUnited statesNorth carolinaJulien valtonPascalyne wilsonArthur strilCellecti pulseagileAshleyr robinsonPatricia sosa navarroCellectis the company euronext growthSecurities exchange commissionNature communicationsEuronext growthVice president gene therapyAdult hemoglobin

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

North carolinaUnited statesWinston salemNew yorkBruce culletonEthan holdawayExchange commissionCompany classEquity syndicate prospectus departmentGuggenheim securitiesEquity syndicate departmentProkidney corpCompany at prokidney corpLifesci advisorsBroadridge financial solutionsJp morgan securities

Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Natalie badilloCorey davisHead of corporate communicationsCrinetics pharmaceuticalsCompensation committee of crinetic board directorsCrinetics pharmaceuticals incLifesci advisorsCompensation committeeCrinetic boardInducement incentive award planNasdaq listing ruleNasdaq global select marketSci advisorsCorporate communications

Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Corey davisNatalie badilloCrinetics pharmaceuticalsHead of corporate communicationsCrinetics pharmaceuticals incLifesci advisorsCompensation committee of crinetic board directorsCrinetics pharmaceuticals announcesPharmaceuticals announces juneGrants under nasdaq listing ruleCompensation committeeCrinetic boardInducement incentive award planNasdaq listing ruleNasdaq global select marketSci advisors